Status:
UNKNOWN
Trans-aortic Valve Replacement and Renal Infarction
Lead Sponsor:
Sheba Medical Center
Conditions:
Renal Infarction
Eligibility:
All Genders
18-99 years
Brief Summary
Kidney Magnetic Resonance assessment before and after undergoing transcatheter aortic valve replacement
Detailed Description
Each patient will undergo Magnetic Resonance assessment of the kidneys before the TAVR. on the third to 7th day after the ATVR, a second MRI to the kidneys will be performed. we will assess the change...
Eligibility Criteria
Inclusion
- Severe symptomatic aortic stenosis
- Patient is able to lay down supine for 20 min (the time needed to perform the MRI) without any difficulties.
Exclusion
- Patient is on chronic renal replacement therapy (Dialysis)
- Documented Thrombus in the left ventricle or left atria
Key Trial Info
Start Date :
April 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2018
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03474250
Start Date
April 1 2018
End Date
December 31 2018
Last Update
May 1 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sheba Medical Center
Ramat Gan, Israel